CLDN3 and ovarian cancer: found that knocking down the expression of Claudin 3(CLDN3) resulted in significant changes in the phenotype of ovarian cancer cells, and further studies found that this would significantly downregulate the expression level of E-cadherin and upregulate the expression of N-cadherin.